You just read:

Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy

News provided by

Proteostasis Therapeutics, Inc.

Jun 06, 2018, 04:05 ET